Brian McNamee
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Brian McNamee
Chair, Independent Non-executive Director / CSL
Dr Brian McNamee AO has executive experience in the biopharmaceutical industry, with a focus on strategy and creating long-term shareholder value. He also has global perspective and understanding of long-term capital projects in the pharmaceutical industry, with proven health, safety, environment and corporate responsibility.
Dr McNamee was a senior advisor to private equity group Kohlberg Kravis Roberts. He has also pursued a number of private equity and interests in small cap healthcare companies, and in 2014 served on the panel of the Australian Government's Financial System Inquiry.
In 2009, he was made an Officer of the Order of Australia for services to business and commerce.
Dr McNamee was a senior advisor to private equity group Kohlberg Kravis Roberts. He has also pursued a number of private equity and interests in small cap healthcare companies, and in 2014 served on the panel of the Australian Government's Financial System Inquiry.
In 2009, he was made an Officer of the Order of Australia for services to business and commerce.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 523rd | CSL | 25% | 4% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | CSL | $22,343.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Chair, Independent Non-executive Director, CSL | 03 Nov 2020 |
